Carl Zeiss Meditec AG Unsponsored ADR (CZMWY)

Market Closed

11 Aug, 20:00

OTC PINK

35. 82

+1.19

+3.4483%

3.03B Market Cap

- P/E Ratio

4.4% Div Yield

2,659 Volume

- Eps

$ 34.63

Previous Close

Add Transaction

Day Range

35.4 35.82

Year Range

26.65 55.94

Want to track CZMWY and more in your Portfolio? 🎯

Get Started For Free

Carl Zeiss Meditec AG (CZMWY) Q3 2026 Earnings Call Transcript

Seekingalpha | 15 hours ago

Carl Zeiss Meditec AG (CZMWY) Q2 2026 Earnings Call Transcript

Seekingalpha | 3 months ago

Carl Zeiss Meditec AG (CZMWY) Q1 2026 Earnings Call Transcript

Seekingalpha | 5 months ago

Carl Zeiss Meditec AG (CZMWY) Q4 2025 Earnings Call Transcript

Seekingalpha | 7 months ago

Carl Zeiss Meditec AG (CZMWY) Discusses CEO Transition and Management Continuity Strategy Following Code of Conduct Investigation Transcript

Seekingalpha | 8 months ago

Carl Zeiss: Why I Am So Positive

Carl Zeiss Meditec is a high-quality MedTech company with a strong market position, low debt, and significant long-term upside potential despite current macroeconomic challenges. The company's fundamentals remain robust, with impressive free cash flow, rising shareholder equity, and a history of maintaining high margins and recurring sales. At sub-€60/share, Carl Zeiss Meditec offers an attractive buy opportunity, with forecasts indicating a significant recovery and upside between 2025 and 2028.

Seekingalpha | 1 year ago

Blog Affiliate Program About Terms Privacy Help Contact Us